NCT06230861

Effects of Quercetin on Cardiometabolic Outcomes

Effects of Quercetin Supplementation on Cardiometabolic Parameters

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: University of Central Lancashire · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated that Quercetin may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.

Conditions

• Cardiometabolic Syndrome

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Quercetin	Quercetin tablets 500mg 1 x per day
OTHER	Placebo	Placebo control 1 x blinded placebo tablet per day

Timeline

• Start date: 2024-03-01
• Primary completion: 2026-08-01
• Completion: 2026-12-01
• First posted: 2024-01-30
• Last updated: 2026-02-27

Locations

1 site across 1 country: United Kingdom